Parkinson's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Parkinson's Disease, including details on symptoms, treatment, genetics, medication.

Volume 4 (2007), Issue 3 (March)

1. High-frequency stimulation of the subthalamic nucleus potentiates L-DOPA-induced neurochemical changes in the striatum in a rat model of Parkinson's disease.
   J Neurosci, 27(9): 2377-86. [Abstract] [Full-text]
2. Glutathione S-transferase polymorphisms and onset age in alpha-synuclein A53T mutant Parkinson's disease.
   Am J Med Genet B Neuropsychiatr Genet, 144(2): 254-8. [Abstract] [Full-text]
3. Temporal relationship between cigarette smoking and risk of Parkinson disease.
   Neurology, 68(10): 764-8. [Abstract] [Full-text]
4. Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage.
   BMC Med Genet, 8: 6. [Abstract] [Full-text]
5. CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease.
   Neurobiol Aging, 28(5): 742-7. [Abstract] [Full-text]
6. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.
   Neurology, 68(11): 812-9. [Abstract] [Full-text]
7. Parkinson's disease and driving ability.
   J Neurol Neurosurg Psychiatry, 78(4): 363-6. [Abstract] [Full-text]
8. The progression of Parkinson disease: a hypothesis.
   Neurology, 68(12): 948-52. [Abstract] [Full-text]
9. Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease.
   Neurology, 68(12): 911-5. [Abstract] [Full-text]
10. Feedback-based versus observational classification learning in healthy aging and Parkinson's disease.
    Brain Res, 1142: 178-88. [Abstract] [Full-text]
11. Duodenal levodopa infusion for the treatment of Parkinson's disease.
    Expert Opin Pharmacother, 8(5): 657-64. [Abstract] [Full-text]
12. Validation of PDQ-8 as an independent instrument in English and Chinese.
    J Neurol Sci, 255(1): 77-80. [Abstract] [Full-text]
13. Assessment of valvulopathy in Parkinson's disease patients on pergolide and/or cabergoline.
    Clin Neurol Neurosurg, 109(4): 350-3. [Abstract] [Full-text]
14. Entacapone improves complex movement performance in patients with Parkinson's disease.
    J Clin Neurosci, 14(5): 424-8. [Abstract] [Full-text]
15. Neuroprotection in Parkinson's disease: an elusive goal.
    Semin Neurol, 27(2): 106-12. [Abstract] [Full-text]
16. Drug therapy for Parkinson's disease.
    Semin Neurol, 27(2): 97-105. [Abstract] [Full-text]
17. Cognitive slowing in Parkinson disease is accompanied by hypofunctioning of the striatum.
    Neurology, 68(13): 1062-8. [Abstract] [Full-text]

© 2004-2008 Parkinson's Disease Research Today. All Rights Reserved.